PubmedID,Title,Publication Date,Non-academic Author(s),Company Affiliation(s),Corresponding Author Email
40684139,Understanding barriers to breast screening: an online survey of non-attenders as part of a service evaluation in the breast screening programme in England.,2025,Sue Hudson,"Peel & Schriek Consulting Ltd, London, UK.",Not found
40681056,Low Dose-Averaged LET Contributes to Local Recurrence of Pancreatic Cancer Treated with Carbon Ion Radiotherapy.,2025,Hanae Yoshida,"Hitachi, Ltd. Research & Development Group, Kokubunji, Japan.",Not found
40680752,"Patient-reported outcomes with belantamab mafodotin, bortezomib, and dexamethasone versus daratumumab, bortezomib, and dexamethasone in patients with relapsed or refractory multiple myeloma (DREAMM-7): results from a phase 3, open-label, randomised controlled trial.",2025,Angely Loubert; Laurine Bunod; Manal M'Hari,"Modus Outcomes, a THREAD Company, Lyon, France.; Modus Outcomes, a THREAD Company, Lyon, France.; Modus Outcomes, a THREAD Company, Lyon, France.",Not found
40679792,"MET Alterations in Cancer and MET-Targeted Therapy: Detection Strategies, Treatment Efficacy, and Emerging Technologies.",2025,Hun Seok Lee; Chae Rin Kim,"Cichlid Corporation, Seoul, Republic of Korea.; Abion Inc, Seoul, Republic of Korea.",Not found
40676580,Enhancing the potency of 5T4 mRNA vaccine by CD70 mRNA-LNPs through ADCC and T cell boosting in prostate cancer therapy.,2025,Kexin Zhang; Ze Xiu Xiao,"Research and development center, Shenzhen MagicRNA Biotech, Shenzhen, CN518107, Guangdong, China.; Research and development center, Shenzhen MagicRNA Biotech, Shenzhen, CN518107, Guangdong, China. xiaozexiu@hotmail.com.",Not found
